Dr. David Braxton, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 1,441
Licensed in California since 2015, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
CA license A137362 (first issued 2015; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hoag Memorial Hospital Presbyterian Newport Beach, CA
- Hoag Orthopedic Institute Irvine, CA
Medical groups
- Newport Harbor PAthology Medical Group Inc (27 clinicians)
- Christopher Evan Lee MD Inc (3 clinicians)
- Homeira Mehrabian MD Inc (2 clinicians)
- Richard G Quist MD Medical Corporation Inc (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,441
- Services billed
- 7,938
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 5,794 | 1,923 |
| Special stained specimen slides to examine tissue, each additional procedure | 479 | 106 |
| Pathology examination of tissue using a microscope, moderately high complexity | 278 | 154 |
| Special stained specimen slides to examine tissue, initial procedure | 157 | 136 |
| Microscopic genetic analysis of tumor, manual | 130 | 49 |
| Special stained specimen slides to examine tissue including interpretation and report | 120 | 55 |
| Special stained specimen slides to identify organisms including interpretation and report | 82 | 54 |
| Pathology examination of tissue using a microscope, moderately low complexity | 76 | 71 |
| Pathology examination of specimen during surgery, first tissue block | 75 | 48 |
| Pathology examination of tissue using a microscope, high complexity | 53 | 47 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $125 in total to this clinician.
| Caris Mpi, Inc. | $125 |
|---|
| Food and Beverage | $125 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.